Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-29
DOI
10.3389/fimmu.2019.01144
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adjuvant strategies to improve vaccination of the elderly population
- (2018) Birgit Weinberger CURRENT OPINION IN PHARMACOLOGY
- Mycobacterium tuberculosis ESAT6 induces IFN-β gene expression in Macrophages via TLRs-mediated signaling
- (2018) Ah-Ra Jang et al. CYTOKINE
- Flagellin as a vaccine adjuvant
- (2018) Baofeng Cui et al. Expert Review of Vaccines
- Edward Jenner’s 1798 report of challenge experiments demonstrating the protective effects of cowpox against smallpox
- (2018) Alfredo Morabia JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
- Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
- (2018) Giuseppe Del Giudice et al. SEMINARS IN IMMUNOLOGY
- Pneumococcal DnaJ modulates dendritic cell-mediated Th1 and Th17 immune responses through Toll-like receptor 4 signaling pathway
- (2017) Yingying Wu et al. IMMUNOBIOLOGY
- Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake
- (2017) Frank Liang et al. Science Translational Medicine
- Mycobacterium tuberculosis MymA is a TLR2 agonist that activate macrophages and a T H 1 response
- (2017) Iti Saraav et al. TUBERCULOSIS
- Subcutaneous Immunization with Fusion Protein DnaJ-ΔA146Ply without Additional Adjuvants Induces both Humoral and Cellular Immunity against Pneumococcal Infection Partially Depending on TLR4
- (2017) Yufeng Su et al. Frontiers in Immunology
- The TLR2 Binding Neisserial Porin PorB Enhances Antigen Presenting Cell Trafficking and Cross-presentation
- (2017) Michael L. Reiser et al. Scientific Reports
- Streptococcus pneumoniae Endopeptidase O (PepO) Elicits a Strong Innate Immune Response in Mice via TLR2 and TLR4 Signaling Pathways
- (2016) Hong Zhang et al. Frontiers in Cellular and Infection Microbiology
- Mycobacterium tuberculosisRpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells
- (2015) Han-Gyu Choi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Vibrio cholerae porin OmpU mediates M1-polarization of macrophages/monocytes via TLR1/TLR2 activation
- (2015) Junaid Khan et al. IMMUNOBIOLOGY
- Molecular signatures of vaccine adjuvants
- (2015) Thorunn Olafsdottir et al. VACCINE
- Interaction ofBordetella pertussisfilamentous hemagglutinin with human TLR2: identification of the TLR2-binding domain
- (2014) Hossein Asgarian-Omran et al. APMIS
- TLR2 and TLR4 signaling pathways are required for recombinant Brucella abortus BCSP31-induced cytokine production, functional upregulation of mouse macrophages and the Th1 immune response in vivo and in vitro
- (2014) Jia-Yun Li et al. Cellular & Molecular Immunology
- Vaccines for the 21st century
- (2014) I. Delany et al. EMBO Molecular Medicine
- The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells
- (2014) A. Seubert et al. JOURNAL OF IMMUNOLOGY
- The contribution of vaccination to global health: past, present and future
- (2014) B. Greenwood PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy
- (2014) Seung Jun Lee et al. PLoS One
- Outer Membrane Protein A (OmpA) of Shigella flexneri 2a Induces TLR2-Mediated Activation of B Cells: Involvement of Protein Tyrosine Kinase, ERK and NF-κB
- (2014) Rajsekhar Bhowmick et al. PLoS One
- TLR-dependent phagosome tubulation in dendritic cells promotes phagosome cross-talk to optimize MHC-II antigen presentation
- (2014) A. R. Mantegazza et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting TLR2 for Vaccine Development
- (2014) Afonso P. Basto et al. Journal of Immunology Research
- Vaccine strategies to enhance immune responses in the aged
- (2013) Julie S Lefebvre et al. CURRENT OPINION IN IMMUNOLOGY
- Outer membrane protein A (OmpA) from Shigella flexneri 2a: A promising subunit vaccine candidate
- (2013) Debasis Pore et al. VACCINE
- MHC Class II Antigen Presentation by Dendritic Cells Regulated through Endosomal Sorting
- (2013) T. ten Broeke et al. Cold Spring Harbor Perspectives in Biology
- The FomA Porin from Fusobacterium nucleatum Is a Toll-Like Receptor 2 Agonist with Immune Adjuvant Activity
- (2012) Deana N. Toussi et al. Clinical and Vaccine Immunology
- Toll-Like Receptor 2-Dependent Activity of Native Major Outer Membrane Protein Proteosomes of Chlamydia trachomatis
- (2012) Paola Massari et al. INFECTION AND IMMUNITY
- The Meningococcal Adhesin NhhA Provokes Proinflammatory Responses in Macrophages via Toll-Like Receptor 4-Dependent and -Independent Pathways
- (2012) Mikael Sjölinder et al. INFECTION AND IMMUNITY
- Mycobacterium paratuberculosisCobT Activates Dendritic Cells via Engagement of Toll-like Receptor 4 Resulting in Th1 Cell Expansion
- (2012) Eui-Hong Byun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Outer Membrane Protein A (OmpA) ofShigella flexneri2a Links Innate and Adaptive Immunity in a TLR2-dependent Manner and Involvement of IL-12 and Nitric Oxide
- (2012) Debasis Pore et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vaxjo: A Web-Based Vaccine Adjuvant Database and Its Application for Analysis of Vaccine Adjuvants and Their Uses in Vaccine Development
- (2012) Samantha Sayers et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Presentation of Phagocytosed Antigens by MHC Class I and II
- (2012) Adriana R. Mantegazza et al. TRAFFIC
- Enhanced Efficacy of Therapeutic Cancer Vaccines Produced by Co-Treatment with Mycobacterium tuberculosis Heparin-Binding Hemagglutinin, a Novel TLR4 Agonist
- (2011) I. D. Jung et al. CANCER RESEARCH
- Defending the mucosa: adjuvant and carrier formulations for mucosal immunity
- (2011) Louise B Lawson et al. CURRENT OPINION IN IMMUNOLOGY
- An Oral Vaccine Based on U-Omp19 Induces Protection against B. abortus Mucosal Challenge by Inducing an Adaptive IL-17 Immune Response in Mice
- (2011) Karina A. Pasquevich et al. PLoS One
- The Structural Biology of Toll-like Receptors
- (2011) Istvan Botos et al. STRUCTURE
- Early Secreted Antigen ESAT-6 of Mycobacterium tuberculosis Promotes Protective T Helper 17 Cell Responses in a Toll-Like Receptor-2-dependent Manner
- (2011) Samit Chatterjee et al. PLoS Pathogens
- Vaccination in the elderly
- (2011) Evelyna Derhovanessian et al. Microbial Biotechnology
- Innate immune function of the neisserial porins and the relationship to vaccine adjuvant activity
- (2010) Lee M Wetzler Future Microbiology
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Human Airway Epithelial Cell Responses to Neisseria lactamica and Purified Porin via Toll-Like Receptor 2-Dependent Signaling
- (2010) X. Liu et al. INFECTION AND IMMUNITY
- Flagellin as an Adjuvant: Cellular Mechanisms and Potential
- (2010) S. B. Mizel et al. JOURNAL OF IMMUNOLOGY
- TLR 2 and CD14 Mediate Innate Immunity and Lung Inflammation to Staphylococcal Panton-Valentine Leukocidin In Vivo
- (2010) A. Zivkovic et al. JOURNAL OF IMMUNOLOGY
- The Protein Moiety of Brucella abortus Outer Membrane Protein 16 Is a New Bacterial Pathogen-Associated Molecular Pattern That Activates Dendritic Cells In Vivo, Induces a Th1 Immune Response, and Is a Promising Self-Adjuvanting Vaccine against Systemic and Oral Acquired Brucellosis
- (2010) K. A. Pasquevich et al. JOURNAL OF IMMUNOLOGY
- 34kDa MOMP of Shigella flexneri promotes TLR2 mediated macrophage activation with the engagement of NF-κB and p38 MAP kinase signaling
- (2010) Debasis Pore et al. MOLECULAR IMMUNOLOGY
- Unmet needs in modern vaccinology
- (2010) Geert Leroux-Roels VACCINE
- Recognition of Lipopeptide Patterns by Toll-like Receptor 2-Toll-like Receptor 6 Heterodimer
- (2009) Jin Young Kang et al. IMMUNITY
- Porin of Shigella dysenteriae directly promotes Toll-like receptor 2-mediated CD4+ T cell survival and effector function
- (2009) Amlan Biswas et al. MOLECULAR IMMUNOLOGY
- Mechanism of action of licensed vaccine adjuvants
- (2009) Elaine Tritto et al. VACCINE
- Phagocytosis and antigen presentation: a partnership initiated by Toll-like receptors
- (2008) J M. Blander ANNALS OF THE RHEUMATIC DISEASES
- The leucine-rich repeat structure
- (2008) J. Bella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
- (2008) C. R. Casella et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Bordetella pertussisfilamentous hemagglutinin delivered by mucosal routes enhances immunoglobulin levels in serum and mucosal fluids
- (2008) Odile Poulain-Godefroy et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Structures of the Toll-like Receptor Family and Its Ligand Complexes
- (2008) Mi Sun Jin et al. IMMUNITY
- Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens
- (2008) Yvonne Perrie et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
- (2008) Mirjam Kool et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Molecular and cellular signatures of human vaccine adjuvants
- (2008) F. Mosca et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now